AVTR
Price
$13.31
Change
+$0.12 (+0.91%)
Updated
Sep 5 closing price
Capitalization
9.07B
48 days until earnings call
RGEN
Price
$124.56
Change
+$3.98 (+3.30%)
Updated
Sep 5 closing price
Capitalization
7.01B
59 days until earnings call
Interact to see
Advertisement

AVTR vs RGEN

Header iconAVTR vs RGEN Comparison
Open Charts AVTR vs RGENBanner chart's image
Avantor
Price$13.31
Change+$0.12 (+0.91%)
Volume$7.67M
Capitalization9.07B
Repligen
Price$124.56
Change+$3.98 (+3.30%)
Volume$1.04M
Capitalization7.01B
AVTR vs RGEN Comparison Chart in %
Loading...
AVTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTR vs. RGEN commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTR is a Buy and RGEN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AVTR: $13.31 vs. RGEN: $124.56)
Brand notoriety: AVTR and RGEN are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AVTR: 64% vs. RGEN: 132%
Market capitalization -- AVTR: $9.07B vs. RGEN: $7.01B
AVTR [@Pharmaceuticals: Other] is valued at $9.07B. RGEN’s [@Pharmaceuticals: Other] market capitalization is $7.01B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTR’s FA Score shows that 0 FA rating(s) are green whileRGEN’s FA Score has 1 green FA rating(s).

  • AVTR’s FA Score: 0 green, 5 red.
  • RGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, RGEN is a better buy in the long-term than AVTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTR’s TA Score shows that 7 TA indicator(s) are bullish while RGEN’s TA Score has 6 bullish TA indicator(s).

  • AVTR’s TA Score: 7 bullish, 3 bearish.
  • RGEN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, AVTR is a better buy in the short-term than RGEN.

Price Growth

AVTR (@Pharmaceuticals: Other) experienced а -1.19% price change this week, while RGEN (@Pharmaceuticals: Other) price change was +1.83% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

AVTR is expected to report earnings on Oct 24, 2025.

RGEN is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVTR($9.07B) has a higher market cap than RGEN($7.01B). RGEN has higher P/E ratio than AVTR: RGEN (521.44) vs AVTR (13.18). RGEN YTD gains are higher at: -13.464 vs. AVTR (-36.830). AVTR has higher annual earnings (EBITDA): 1.41B vs. RGEN (99.5M). RGEN has more cash in the bank: 709M vs. AVTR (449M). RGEN has less debt than AVTR: RGEN (686M) vs AVTR (4.24B). AVTR has higher revenues than RGEN: AVTR (6.67B) vs RGEN (674M).
AVTRRGENAVTR / RGEN
Capitalization9.07B7.01B129%
EBITDA1.41B99.5M1,418%
Gain YTD-36.830-13.464274%
P/E Ratio13.18521.443%
Revenue6.67B674M989%
Total Cash449M709M63%
Total Debt4.24B686M619%
FUNDAMENTALS RATINGS
AVTR vs RGEN: Fundamental Ratings
AVTR
RGEN
OUTLOOK RATING
1..100
7963
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6492
PRICE GROWTH RATING
1..100
6262
P/E GROWTH RATING
1..100
992
SEASONALITY SCORE
1..100
5550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVTR's Valuation (71) in the null industry is in the same range as RGEN (95) in the Biotechnology industry. This means that AVTR’s stock grew similarly to RGEN’s over the last 12 months.

AVTR's Profit vs Risk Rating (100) in the null industry is in the same range as RGEN (100) in the Biotechnology industry. This means that AVTR’s stock grew similarly to RGEN’s over the last 12 months.

AVTR's SMR Rating (64) in the null industry is in the same range as RGEN (92) in the Biotechnology industry. This means that AVTR’s stock grew similarly to RGEN’s over the last 12 months.

AVTR's Price Growth Rating (62) in the null industry is in the same range as RGEN (62) in the Biotechnology industry. This means that AVTR’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for AVTR (99) in the null industry. This means that RGEN’s stock grew significantly faster than AVTR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVTRRGEN
RSI
ODDS (%)
Bullish Trend 2 days ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
AVTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FEMS43.990.55
+1.26%
First Trust Emerg Mkts SC AlphaDEX® ETF
SMCZ5.780.07
+1.23%
Defiance Daily Target 2X Short SMCI ETF
SXQG33.300.13
+0.39%
ETC 6 Meridian Quality Growth ETF
QQQE97.940.17
+0.17%
Direxion NASDAQ-100® Equal Wtd ETF
YXI10.28-0.12
-1.20%
ProShares Short FTSE China 50

AVTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTR has been loosely correlated with RGEN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AVTR jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTR
1D Price
Change %
AVTR100%
+0.91%
RGEN - AVTR
48%
Loosely correlated
+3.30%
ATR - AVTR
44%
Loosely correlated
+0.12%
SOLV - AVTR
43%
Loosely correlated
+0.47%
AZTA - AVTR
43%
Loosely correlated
+2.64%
BCPC - AVTR
39%
Loosely correlated
-0.15%
More

RGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGEN has been closely correlated with DHR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if RGEN jumps, then DHR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEN
1D Price
Change %
RGEN100%
+3.30%
DHR - RGEN
67%
Closely correlated
+0.59%
A - RGEN
66%
Loosely correlated
+0.21%
BIO - RGEN
63%
Loosely correlated
+2.07%
MTD - RGEN
61%
Loosely correlated
+1.39%
BLFS - RGEN
59%
Loosely correlated
+2.28%
More